Results
|
1.
|
|
|
2.
|
|
|
3.
|
Cultivation-dependent plasticity of melanoma phenotype. [electronic resource] by
- Kodet, Ondřej
- Dvořánková, Barbora
- Krejčí, Eliška
- Szabo, Pavol
- Dvořák, Petr
- Štork, Jiří
- Krajsová, Ivana
- Dundr, Pavel
- Smetana, Karel
- Lacina, Lukáš
Producer: 20140221
In:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine vol. 34
Availability: No items available.
|
|
4.
|
KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients. [electronic resource] by
- Janku, Filip
- Novotny, Jan
- Julis, Ivan
- Julisova, Ivana
- Pecen, Ladislav
- Tomancova, Vera
- Kocmanova, Gabriela
- Krasna, Luboslava
- Krajsova, Ivana
- Stork, Jiri
- Petruzelka, Lubos
Producer: 20060522
In:
Melanoma research vol. 15
Availability: No items available.
|
|
5.
|
Microenvironment‑driven resistance to B‑Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts. [electronic resource] by
- Kodet, Ondřej
- Dvořánková, Barbora
- Bendlová, Běla
- Sýkorová, Vlasta
- Krajsová, Ivana
- Štork, Jiří
- Kučera, Jan
- Szabo, Pavol
- Strnad, Hynek
- Kolář, Michal
- Vlček, Čestmír
- Smetana, Karel
- Lacina, Lukáš
Producer: 20180827
In:
International journal of molecular medicine vol. 41
Availability: No items available.
|
|
6.
|
Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study. [electronic resource] by
- Kučera, Jan
- Strnadová, Karolína
- Dvořánková, Barbora
- Lacina, Lukáš
- Krajsová, Ivana
- Štork, Jiří
- Kovářová, Hana
- Skalníková, Helena Kupcová
- Vodička, Petr
- Motlík, Jan
- Dundr, Pavel
- Smetana, Karel
- Kodet, Ondřej
Producer: 20200323
In:
Oncology reports vol. 42
Availability: No items available.
|
|
7.
|
Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma. [electronic resource] by
- Ascierto, Paolo A
- Dummer, Reinhard
- Gogas, Helen J
- Flaherty, Keith T
- Arance, Ana
- Mandala, Mario
- Liszkay, Gabriella
- Garbe, Claus
- Schadendorf, Dirk
- Krajsova, Ivana
- Gutzmer, Ralf
- de Groot, Jan Willem B
- Loquai, Carmen
- Gollerkeri, Ashwin
- Pickard, Michael D
- Robert, Caroline
Producer: 20200803
In:
European journal of cancer (Oxford, England : 1990) vol. 126
Availability: No items available.
|
|
8.
|
Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management. [electronic resource] by
- Gogas, Helen J
- Flaherty, Keith T
- Dummer, Reinhard
- Ascierto, Paolo A
- Arance, Ana
- Mandala, Mario
- Liszkay, Gabriella
- Garbe, Claus
- Schadendorf, Dirk
- Krajsova, Ivana
- Gutzmer, Ralf
- Sileni, Vanna Chiarion
- Dutriaux, Caroline
- de Groot, Jan Willem B
- Yamazaki, Naoya
- Loquai, Carmen
- Gollerkeri, Ashwin
- Pickard, Michael D
- Robert, Caroline
Producer: 20200608
In:
European journal of cancer (Oxford, England : 1990) vol. 119
Availability: No items available.
|
|
9.
|
Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF [electronic resource] by
- Blank, Christian U
- Larkin, James
- Arance, Ana M
- Hauschild, Axel
- Queirolo, Paola
- Del Vecchio, Michele
- Ascierto, Paolo A
- Krajsova, Ivana
- Schachter, Jacob
- Neyns, Bart
- Garbe, Claus
- Chiarion Sileni, Vanna
- Mandalà, Mario
- Gogas, Helen
- Espinosa, Enrique
- Hospers, Geke A P
- Miller, Wilson H
- Robson, Susan
- Makrutzki, Martina
- Antic, Vladan
- Brown, Michael P
Producer: 20170821
In:
European journal of cancer (Oxford, England : 1990) vol. 79
Availability: No items available.
|
|
10.
|
Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study. [electronic resource] by
- Larkin, James
- Del Vecchio, Michele
- Ascierto, Paolo A
- Krajsova, Ivana
- Schachter, Jacob
- Neyns, Bart
- Espinosa, Enrique
- Garbe, Claus
- Sileni, Vanna Chiarion
- Gogas, Helen
- Miller, Wilson H
- Mandalà, Mario
- Hospers, Geke A P
- Arance, Ana
- Queirolo, Paola
- Hauschild, Axel
- Brown, Michael P
- Mitchell, Lada
- Veronese, Luisa
- Blank, Christian U
Producer: 20140703
In:
The Lancet. Oncology vol. 15
Availability: No items available.
|
|
11.
|
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial. [electronic resource] by
- Dummer, Reinhard
- Ascierto, Paolo A
- Gogas, Helen J
- Arance, Ana
- Mandala, Mario
- Liszkay, Gabriella
- Garbe, Claus
- Schadendorf, Dirk
- Krajsova, Ivana
- Gutzmer, Ralf
- Chiarion Sileni, Vanna
- Dutriaux, Caroline
- de Groot, Jan Willem B
- Yamazaki, Naoya
- Loquai, Carmen
- Moutouh-de Parseval, Laure A
- Pickard, Michael D
- Sandor, Victor
- Robert, Caroline
- Flaherty, Keith T
Producer: 20190617
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|
|
12.
|
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial. [electronic resource] by
- Dummer, Reinhard
- Ascierto, Paolo A
- Gogas, Helen J
- Arance, Ana
- Mandala, Mario
- Liszkay, Gabriella
- Garbe, Claus
- Schadendorf, Dirk
- Krajsova, Ivana
- Gutzmer, Ralf
- Chiarion-Sileni, Vanna
- Dutriaux, Caroline
- de Groot, Jan Willem B
- Yamazaki, Naoya
- Loquai, Carmen
- Moutouh-de Parseval, Laure A
- Pickard, Michael D
- Sandor, Victor
- Robert, Caroline
- Flaherty, Keith T
Producer: 20190409
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|
|
13.
|
An open-label, multicentre safety study of vemurafenib in patients with BRAF [electronic resource] by
- Larkin, James
- Brown, Michael P
- Arance, Ana M
- Hauschild, Axel
- Queirolo, Paola
- Vecchio, Michele Del
- Ascierto, Paolo A
- Krajsová, Ivana
- Schachter, Jacob
- Neyns, Bart
- Garbe, Claus
- Sileni, Vanna Chiarion
- Mandalà, Mario
- Gogas, Helen
- Espinosa, Enrique
- Hospers, Geke
- Lorigan, Paul
- Nyakas, Marta
- Guminski, Alex
- Liszkay, Gabriela
- Rutkowski, Piotr
- Miller, Wilson
- Donica, Margarita
- Makrutzki, Martina
- Blank, Christian
Producer: 20200504
In:
European journal of cancer (Oxford, England : 1990) vol. 107
Availability: No items available.
|
|
14.
|
Improved overall survival in melanoma with combined dabrafenib and trametinib. [electronic resource] by
- Robert, Caroline
- Karaszewska, Boguslawa
- Schachter, Jacob
- Rutkowski, Piotr
- Mackiewicz, Andrzej
- Stroiakovski, Daniil
- Lichinitser, Michael
- Dummer, Reinhard
- Grange, Florent
- Mortier, Laurent
- Chiarion-Sileni, Vanna
- Drucis, Kamil
- Krajsova, Ivana
- Hauschild, Axel
- Lorigan, Paul
- Wolter, Pascal
- Long, Georgina V
- Flaherty, Keith
- Nathan, Paul
- Ribas, Antoni
- Martin, Anne-Marie
- Sun, Peng
- Crist, Wendy
- Legos, Jeff
- Rubin, Stephen D
- Little, Shonda M
- Schadendorf, Dirk
Producer: 20150107
In:
The New England journal of medicine vol. 372
Availability: No items available.
|
|
15.
|
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. [electronic resource] by
- Dreno, Brigitte
- Thompson, John F
- Smithers, Bernard Mark
- Santinami, Mario
- Jouary, Thomas
- Gutzmer, Ralf
- Levchenko, Evgeny
- Rutkowski, Piotr
- Grob, Jean-Jacques
- Korovin, Sergii
- Drucis, Kamil
- Grange, Florent
- Machet, Laurent
- Hersey, Peter
- Krajsova, Ivana
- Testori, Alessandro
- Conry, Robert
- Guillot, Bernard
- Kruit, Wim H J
- Demidov, Lev
- Thompson, John A
- Bondarenko, Igor
- Jaroszek, Jaroslaw
- Puig, Susana
- Cinat, Gabriela
- Hauschild, Axel
- Goeman, Jelle J
- van Houwelingen, Hans C
- Ulloa-Montoya, Fernando
- Callegaro, Andrea
- Dizier, Benjamin
- Spiessens, Bart
- Debois, Muriel
- Brichard, Vincent G
- Louahed, Jamila
- Therasse, Patrick
- Debruyne, Channa
- Kirkwood, John M
Producer: 20190408
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|